TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Long-term Follow-up of Treatment with Ibrutinib and Rituximab in Patients with High-Risk Chronic Lymphocytic Leukemia.

Preetesh Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.